These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 112377)

  • 21. Increased formation of 5-fluoro-2'-deoxyuridine 5'-monophosphate from 5-fluorouracil in the presence of 2-deoxy-alpha-D-ribose 1-phosphate and 2'-deoxyuridine in Ehrlich ascites tumor cells.
    Tamemasa O; Tezuka M
    Nucleic Acids Symp Ser; 1980; (8):s169-72. PubMed ID: 7255189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of action of anti-cancer drugs from the viewpoint of RNA metabolism].
    Kanamaru R; Wakui A
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1011-8. PubMed ID: 3291764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for prediction of chemotherapy response to 5-fluorouracil based on the differential distribution of 5-[18F]fluorouracil in sensitive versus resistant lymphocytic leukemia in mice.
    Shani J; Wolf W
    Cancer Res; 1977 Jul; 37(7 Pt 1):2306-8. PubMed ID: 861951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro.
    Schwartz PM; Handschumacher RE
    Cancer Res; 1979 Aug; 39(8):3095-101. PubMed ID: 455294
    [No Abstract]   [Full Text] [Related]  

  • 25. Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.
    Bennett LL; Allan PW
    Cancer Res; 1971 Feb; 31(2):152-8. PubMed ID: 5545266
    [No Abstract]   [Full Text] [Related]  

  • 26. gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells.
    Vogel FS; Kemper LA; Jeffs PW; Cass MW; Graham DG
    Cancer Res; 1977 Apr; 37(4):1133-6. PubMed ID: 403000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
    Fernandes DJ; Moroson BA; Bertino JR
    Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of the differential cytotoxicity of keto-C-glycosides toward normal and malignant cells.
    Bennani-Baiti IM; Lafarge-Frayssinet C; Herscovici J; Monserret R; Robbana-Barnat S; Antonakis K; Frayssinet C; Uriel J
    Anticancer Res; 1993; 13(2):467-73. PubMed ID: 8517664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.
    Kessel D
    Cancer Res; 1980 Feb; 40(2):322-4. PubMed ID: 7356515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of cyclodepsipeptides on murine lymphocytes and on L 1210 leukemia cells.
    Morel E; Pais M; Turpin M; Guyot M
    Biomed Pharmacother; 1983; 37(4):184-5. PubMed ID: 6661504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 34. [Production by activated lymphocytes of mediators increasing the antitumor cytostatic activity of bone marrow cells].
    Seledtsov VI; Taraban VIa; Seledtsova GV; Seniukov VV; Samarin DM; Kashchenko EA; Kozlov VA
    Biull Eksp Biol Med; 1998 Jun; 125(6):660-2. PubMed ID: 9693761
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of antifolates and folates on the antineoplastic action of fluoropyrimidines].
    Graczyk J
    Postepy Hig Med Dosw; 1992; 46(2):143-58. PubMed ID: 1470578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of combined therapy with methotrexate and 5-fluorouracil from the view point of cellular PRPP level of L1210 cells and HeLa S3 cells.
    Kakuta H; Kanamaru R; Sato T; Ishioka C; Wakui A
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):47-52. PubMed ID: 2428109
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts.
    Pogolotti AL; Nolan PA; Santi DV
    Anal Biochem; 1981 Oct; 117(1):178-86. PubMed ID: 6459042
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. II. Correlation between the tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing mice.
    Reyes P; Hall TC
    Biochem Pharmacol; 1969 Oct; 18(10):2587-90. PubMed ID: 4327386
    [No Abstract]   [Full Text] [Related]  

  • 39. The differential effect of 8-azaguanine on nucleic acid and protein biosynthesis of leukemia L1210.
    BURDGE DC; MANDEL HG
    Cancer Chemother Rep; 1962 May; 18():1-4. PubMed ID: 13874751
    [No Abstract]   [Full Text] [Related]  

  • 40. Transport and intracellular metabolism of fluorinated pyrimidines in cultured cell lines.
    Uchida M; Ho DH; Kamiya K; Yoshimura T; Sasaki K; Tsutani H; Nakamura T
    Adv Exp Med Biol; 1989; 253B():321-6. PubMed ID: 2532860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.